Index by author

December 1, 2006 ;  91 (12)

A

  1. Agostinelli, RM

    1. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia
      W Barcellini, S Capalbo, RM Agostinelli, FR Mauro, A Ambrosetti, R Calori, A Cortelezzi, L Laurenti, EM Pogliani, P Pedotti, V Liso, G Girelli, F Mandelli, A Zanella, GIMEMA Chronic Lymphocytic Leukemia Group
      Haematologica Jan 2006, 91 (12) 1689-1692;

  2. Alvaro, T

    1. The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma
      T Alvaro, M Lejeune, FI Camacho, MT Salvado, L Sanchez, JF Garcia, C Lopez, J Jaen, R Bosch, LE Pons, C Bellas, MA Piris
      Haematologica Jan 2006, 91 (12) 1605-1612;

  3. Amadori, S

    1. Phase II multicenter study of arsenic trioxide, ascorbic acid and dexamethasone in patients with relapsed or refractory multiple myeloma
      KL Wu, M Beksac, J van Droogenbroeck, S Amadori, S Zweegman, P Sonneveld
      Haematologica Jan 2006, 91 (12) 1722-1723;

  4. Ambrosetti, A

    1. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia
      W Barcellini, S Capalbo, RM Agostinelli, FR Mauro, A Ambrosetti, R Calori, A Cortelezzi, L Laurenti, EM Pogliani, P Pedotti, V Liso, G Girelli, F Mandelli, A Zanella, GIMEMA Chronic Lymphocytic Leukemia Group
      Haematologica Jan 2006, 91 (12) 1689-1692;

  5. Anza, M

    1. Analysis of delta-globin gene alleles in the Sicilian population: identification of five new mutations
      A Giambona, C Passarello, G Ruggeri, D Renda, P Teresi, M Anza, A Maggio
      Haematologica Jan 2006, 91 (12) 1681-1684;

  6. Asselta, R

    1. Coagulation factor V gene analysis in five Indian patients: identification of three novel small deletions
      R Asselta, C Dall'Osso, S Duga, M Spreafico, R Saxena, ML Tenchini
      Haematologica Jan 2006, 91 (12) 1724-1726;

  7. Astier, A

    1. Pharmacokinetics of hydroxyurea 1,000 mg coated breakable tablets and 500 mg capsules in pediatric and adult patients with sickle cell disease
      M de Montalembert, D Bachir, A Hulin, L Gimeno, A Mogenet, JL Bresson, I Macquin-Mavier, F Roudot-Thoraval, A Astier, F Galacteros
      Haematologica Jan 2006, 91 (12) 1685-1688;

  8. Aul, C

    1. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes
      U Germing, C Strupp, A Kuendgen, S Isa, S Knipp, B Hildebrandt, A Giagounidis, C Aul, N Gattermann, R Haas
      Haematologica Jan 2006, 91 (12) 1596-1604;

  9. Avanzati, A

    1. The effect of zoledronic acid on serum osteoprotegerin in early stage multiple myeloma
      G Martini, A Gozzetti, L Gennari, A Avanzati, R Nuti, F Lauria
      Haematologica Jan 2006, 91 (12) 1720-1721;

B

  1. Bachir, D

    1. Pharmacokinetics of hydroxyurea 1,000 mg coated breakable tablets and 500 mg capsules in pediatric and adult patients with sickle cell disease
      M de Montalembert, D Bachir, A Hulin, L Gimeno, A Mogenet, JL Bresson, I Macquin-Mavier, F Roudot-Thoraval, A Astier, F Galacteros
      Haematologica Jan 2006, 91 (12) 1685-1688;

  2. Baens, M

    1. Splenic marginal zone lymphoma-like features in API2-MALT1 transgenic mice that are exposed to antigenic stimulation
      X Sagaert, T Theys, C De Wolf-Peeters, P Marynen, M Baens
      Haematologica Jan 2006, 91 (12) 1693-1696;

  3. Bal Dit Sollier, C

    1. Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study
      I Mahe, N Bertrand, L Drouet, C Bal Dit Sollier, G Simoneau, E Mazoyer, C Caulin, JF Bergmann
      Haematologica Jan 2006, 91 (12) 1621-1627;

  4. Bandini, G

    1. Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation
      M Brugiatelli, G Bandini, G Barosi, F Lauria, V Liso, M Marchetti, FR Mauro, G Meloni, PL Zinzani, S Tura, Italian Society of Hematology, Italian Society of Experimental Hematology, Italian Group for Bone Marrow Transplantation
      Haematologica Jan 2006, 91 (12) 1662-1673;

  5. Barcellini, W

    1. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia
      W Barcellini, S Capalbo, RM Agostinelli, FR Mauro, A Ambrosetti, R Calori, A Cortelezzi, L Laurenti, EM Pogliani, P Pedotti, V Liso, G Girelli, F Mandelli, A Zanella, GIMEMA Chronic Lymphocytic Leukemia Group
      Haematologica Jan 2006, 91 (12) 1689-1692;

  6. Barendregt, BH

    1. B-cell recovery after stem cell transplantation of Artemis-deficient SCID requires elimination of autologous bone marrow precursor-B-cells
      M van der Burg, CM Weemaes, F Preijers, P Brons, BH Barendregt, MJ van Tol, P Hoogerbrugge, JJ van Dongen
      Haematologica Jan 2006, 91 (12) 1705-1709;

  7. Barosi, G

    1. Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation
      M Brugiatelli, G Bandini, G Barosi, F Lauria, V Liso, M Marchetti, FR Mauro, G Meloni, PL Zinzani, S Tura, Italian Society of Hematology, Italian Society of Experimental Hematology, Italian Group for Bone Marrow Transplantation
      Haematologica Jan 2006, 91 (12) 1662-1673;

  8. Baseggio, L

    1. The expression of TCR-gamma delta/CD3 complex in neoplastic gamma delta T-cell
      L Baseggio, F Berger, G Monneret, JP Magaud, G Salles, P Felman
      Haematologica Jan 2006, 91 (12) 1717-1719;

  9. Beksac, M

    1. Phase II multicenter study of arsenic trioxide, ascorbic acid and dexamethasone in patients with relapsed or refractory multiple myeloma
      KL Wu, M Beksac, J van Droogenbroeck, S Amadori, S Zweegman, P Sonneveld
      Haematologica Jan 2006, 91 (12) 1722-1723;

  10. Bellas, C

    1. The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma
      T Alvaro, M Lejeune, FI Camacho, MT Salvado, L Sanchez, JF Garcia, C Lopez, J Jaen, R Bosch, LE Pons, C Bellas, MA Piris
      Haematologica Jan 2006, 91 (12) 1605-1612;

  11. Berger, F

    1. The expression of TCR-gamma delta/CD3 complex in neoplastic gamma delta T-cell
      L Baseggio, F Berger, G Monneret, JP Magaud, G Salles, P Felman
      Haematologica Jan 2006, 91 (12) 1717-1719;

  12. Bergmann, JF

    1. Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study
      I Mahe, N Bertrand, L Drouet, C Bal Dit Sollier, G Simoneau, E Mazoyer, C Caulin, JF Bergmann
      Haematologica Jan 2006, 91 (12) 1621-1627;

  13. Bertrand, N

    1. Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study
      I Mahe, N Bertrand, L Drouet, C Bal Dit Sollier, G Simoneau, E Mazoyer, C Caulin, JF Bergmann
      Haematologica Jan 2006, 91 (12) 1621-1627;

  14. Bidlingmaier, C

    1. Long-term safety and efficacy data on childhood venous thrombosis treated with a low molecular weight heparin: an open-label pilot study of once-daily versus twice-daily enoxaparin administration
      R Schobess, C During, C Bidlingmaier, A Heinecke, N Merkel, U Nowak-Gottl
      Haematologica Jan 2006, 91 (12) 1701-1704;

  15. Bogunia-Kubik, K

    1. CCR5 deletion mutation and its association with the risk of developing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
      K Bogunia-Kubik, D Duda, K Suchnicki, A Lange
      Haematologica Jan 2006, 91 (12) 1628-1634;

  16. Bosch, R

    1. The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma
      T Alvaro, M Lejeune, FI Camacho, MT Salvado, L Sanchez, JF Garcia, C Lopez, J Jaen, R Bosch, LE Pons, C Bellas, MA Piris
      Haematologica Jan 2006, 91 (12) 1605-1612;

  17. Braakman, E

    1. Myeloproliferative disease in the pathogenesis and survival of Budd-Chiari syndrome
      JH Smalberg, SD Murad, E Braakman, PJ Valk, HL Janssen, FW Leebeek
      Haematologica Jan 2006, 91 (12) 1712-1713;

  18. Bregni, M

    1. Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis
      V Perfetti, S Siena, G Palladini, M Bregni, M Di Nicola, L Obici, M Magni, L Brunetti, AM Gianni, G Merlini
      Haematologica Jan 2006, 91 (12) 1635-1643;

  19. Bresson, JL

    1. Pharmacokinetics of hydroxyurea 1,000 mg coated breakable tablets and 500 mg capsules in pediatric and adult patients with sickle cell disease
      M de Montalembert, D Bachir, A Hulin, L Gimeno, A Mogenet, JL Bresson, I Macquin-Mavier, F Roudot-Thoraval, A Astier, F Galacteros
      Haematologica Jan 2006, 91 (12) 1685-1688;

  20. Brons, P

    1. B-cell recovery after stem cell transplantation of Artemis-deficient SCID requires elimination of autologous bone marrow precursor-B-cells
      M van der Burg, CM Weemaes, F Preijers, P Brons, BH Barendregt, MJ van Tol, P Hoogerbrugge, JJ van Dongen
      Haematologica Jan 2006, 91 (12) 1705-1709;

  21. Brugiatelli, M

    1. Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation
      M Brugiatelli, G Bandini, G Barosi, F Lauria, V Liso, M Marchetti, FR Mauro, G Meloni, PL Zinzani, S Tura, Italian Society of Hematology, Italian Society of Experimental Hematology, Italian Group for Bone Marrow Transplantation
      Haematologica Jan 2006, 91 (12) 1662-1673;

  22. Brunetti, L

    1. Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis
      V Perfetti, S Siena, G Palladini, M Bregni, M Di Nicola, L Obici, M Magni, L Brunetti, AM Gianni, G Merlini
      Haematologica Jan 2006, 91 (12) 1635-1643;

C

  1. Calori, G

    1. Lipoprotein(a), fibrinogen and vascular mortality in an elderly northern Italian population
      A D'Angelo, G Ruotolo, P Garancini, F Sampietro, G Mazzola, G Calori
      Haematologica Jan 2006, 91 (12) 1613-1620;

  2. Calori, R

    1. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia
      W Barcellini, S Capalbo, RM Agostinelli, FR Mauro, A Ambrosetti, R Calori, A Cortelezzi, L Laurenti, EM Pogliani, P Pedotti, V Liso, G Girelli, F Mandelli, A Zanella, GIMEMA Chronic Lymphocytic Leukemia Group
      Haematologica Jan 2006, 91 (12) 1689-1692;

  3. Camacho, FI

    1. The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma
      T Alvaro, M Lejeune, FI Camacho, MT Salvado, L Sanchez, JF Garcia, C Lopez, J Jaen, R Bosch, LE Pons, C Bellas, MA Piris
      Haematologica Jan 2006, 91 (12) 1605-1612;

  4. Capalbo, S

    1. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia
      W Barcellini, S Capalbo, RM Agostinelli, FR Mauro, A Ambrosetti, R Calori, A Cortelezzi, L Laurenti, EM Pogliani, P Pedotti, V Liso, G Girelli, F Mandelli, A Zanella, GIMEMA Chronic Lymphocytic Leukemia Group
      Haematologica Jan 2006, 91 (12) 1689-1692;

  5. Caulin, C

    1. Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study
      I Mahe, N Bertrand, L Drouet, C Bal Dit Sollier, G Simoneau, E Mazoyer, C Caulin, JF Bergmann
      Haematologica Jan 2006, 91 (12) 1621-1627;

  6. Cazzola, M

    1. Predicting survival and leukemic evolution in patients with myelodysplastic syndrome
      L Malcovati, MG Della Porta, M Cazzola
      Haematologica Jan 2006, 91 (12) 1588-1590;

  7. Cortelezzi, A

    1. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia
      W Barcellini, S Capalbo, RM Agostinelli, FR Mauro, A Ambrosetti, R Calori, A Cortelezzi, L Laurenti, EM Pogliani, P Pedotti, V Liso, G Girelli, F Mandelli, A Zanella, GIMEMA Chronic Lymphocytic Leukemia Group
      Haematologica Jan 2006, 91 (12) 1689-1692;

D

  1. D'Angelo, A

    1. Lipoprotein(a), fibrinogen and vascular mortality in an elderly northern Italian population
      A D'Angelo, G Ruotolo, P Garancini, F Sampietro, G Mazzola, G Calori
      Haematologica Jan 2006, 91 (12) 1613-1620;

  2. D'Cruz, DP

    1. Managing antiphospholipid antibodies and antiphospholipid syndrome in children
      AV Kamat, DP D'Cruz, BJ Hunt
      Haematologica Jan 2006, 91 (12) 1674-1680;

  3. Dall'Osso, C

    1. Coagulation factor V gene analysis in five Indian patients: identification of three novel small deletions
      R Asselta, C Dall'Osso, S Duga, M Spreafico, R Saxena, ML Tenchini
      Haematologica Jan 2006, 91 (12) 1724-1726;

  4. Della Porta, MG

    1. Predicting survival and leukemic evolution in patients with myelodysplastic syndrome
      L Malcovati, MG Della Porta, M Cazzola
      Haematologica Jan 2006, 91 (12) 1588-1590;

  5. de Montalembert, M

    1. Pharmacokinetics of hydroxyurea 1,000 mg coated breakable tablets and 500 mg capsules in pediatric and adult patients with sickle cell disease
      M de Montalembert, D Bachir, A Hulin, L Gimeno, A Mogenet, JL Bresson, I Macquin-Mavier, F Roudot-Thoraval, A Astier, F Galacteros
      Haematologica Jan 2006, 91 (12) 1685-1688;

  6. De Wolf-Peeters, C

    1. Splenic marginal zone lymphoma-like features in API2-MALT1 transgenic mice that are exposed to antigenic stimulation
      X Sagaert, T Theys, C De Wolf-Peeters, P Marynen, M Baens
      Haematologica Jan 2006, 91 (12) 1693-1696;

  7. Di Nicola, M

    1. Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis
      V Perfetti, S Siena, G Palladini, M Bregni, M Di Nicola, L Obici, M Magni, L Brunetti, AM Gianni, G Merlini
      Haematologica Jan 2006, 91 (12) 1635-1643;

  8. Dohner, H

    1. Cancer vaccines for patients with acute myeloid leukemia--definition of leukemia-associated antigens and current clinical protocols targeting these antigens
      J Greiner, H Dohner, M Schmitt
      Haematologica Jan 2006, 91 (12) 1653-1661;

  9. Drouet, L

    1. Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study
      I Mahe, N Bertrand, L Drouet, C Bal Dit Sollier, G Simoneau, E Mazoyer, C Caulin, JF Bergmann
      Haematologica Jan 2006, 91 (12) 1621-1627;

  10. Duda, D

    1. CCR5 deletion mutation and its association with the risk of developing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
      K Bogunia-Kubik, D Duda, K Suchnicki, A Lange
      Haematologica Jan 2006, 91 (12) 1628-1634;

  11. Duga, S

    1. Coagulation factor V gene analysis in five Indian patients: identification of three novel small deletions
      R Asselta, C Dall'Osso, S Duga, M Spreafico, R Saxena, ML Tenchini
      Haematologica Jan 2006, 91 (12) 1724-1726;

  12. During, C

    1. Long-term safety and efficacy data on childhood venous thrombosis treated with a low molecular weight heparin: an open-label pilot study of once-daily versus twice-daily enoxaparin administration
      R Schobess, C During, C Bidlingmaier, A Heinecke, N Merkel, U Nowak-Gottl
      Haematologica Jan 2006, 91 (12) 1701-1704;

E

  1. Eggen, BJ

    1. Constitutive activation of NF-kappa B is not sufficient to disturb normal steady-state hematopoiesis
      H Schepers, BJ Eggen, JJ Schuringa, E Vellenga
      Haematologica Jan 2006, 91 (12) 1710-1711;

  2. Engels, EA

    1. Respiratory tract infections in the pathway to multiple myeloma: a population-based study in Scandinavia
      O Landgren, JS Rapkin, L Mellemkjaer, G Gridley, LR Goldin, EA Engels
      Haematologica Jan 2006, 91 (12) 1697-1700;

F

  1. Felman, P

    1. The expression of TCR-gamma delta/CD3 complex in neoplastic gamma delta T-cell
      L Baseggio, F Berger, G Monneret, JP Magaud, G Salles, P Felman
      Haematologica Jan 2006, 91 (12) 1717-1719;

G

  1. Galacteros, F

    1. Pharmacokinetics of hydroxyurea 1,000 mg coated breakable tablets and 500 mg capsules in pediatric and adult patients with sickle cell disease
      M de Montalembert, D Bachir, A Hulin, L Gimeno, A Mogenet, JL Bresson, I Macquin-Mavier, F Roudot-Thoraval, A Astier, F Galacteros
      Haematologica Jan 2006, 91 (12) 1685-1688;

  2. Garancini, P

    1. Lipoprotein(a), fibrinogen and vascular mortality in an elderly northern Italian population
      A D'Angelo, G Ruotolo, P Garancini, F Sampietro, G Mazzola, G Calori
      Haematologica Jan 2006, 91 (12) 1613-1620;

  3. Garcia, JF

    1. The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma
      T Alvaro, M Lejeune, FI Camacho, MT Salvado, L Sanchez, JF Garcia, C Lopez, J Jaen, R Bosch, LE Pons, C Bellas, MA Piris
      Haematologica Jan 2006, 91 (12) 1605-1612;

  4. Gattermann, N

    1. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes
      U Germing, C Strupp, A Kuendgen, S Isa, S Knipp, B Hildebrandt, A Giagounidis, C Aul, N Gattermann, R Haas
      Haematologica Jan 2006, 91 (12) 1596-1604;

  5. Gennari, L

    1. The effect of zoledronic acid on serum osteoprotegerin in early stage multiple myeloma
      G Martini, A Gozzetti, L Gennari, A Avanzati, R Nuti, F Lauria
      Haematologica Jan 2006, 91 (12) 1720-1721;

  6. Germing, U

    1. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes
      U Germing, C Strupp, A Kuendgen, S Isa, S Knipp, B Hildebrandt, A Giagounidis, C Aul, N Gattermann, R Haas
      Haematologica Jan 2006, 91 (12) 1596-1604;

  7. Giagounidis, A

    1. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes
      U Germing, C Strupp, A Kuendgen, S Isa, S Knipp, B Hildebrandt, A Giagounidis, C Aul, N Gattermann, R Haas
      Haematologica Jan 2006, 91 (12) 1596-1604;

  8. Giambona, A

    1. Analysis of delta-globin gene alleles in the Sicilian population: identification of five new mutations
      A Giambona, C Passarello, G Ruggeri, D Renda, P Teresi, M Anza, A Maggio
      Haematologica Jan 2006, 91 (12) 1681-1684;

  9. Gianni, AM

    1. Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis
      V Perfetti, S Siena, G Palladini, M Bregni, M Di Nicola, L Obici, M Magni, L Brunetti, AM Gianni, G Merlini
      Haematologica Jan 2006, 91 (12) 1635-1643;

  10. Gimeno, L

    1. Pharmacokinetics of hydroxyurea 1,000 mg coated breakable tablets and 500 mg capsules in pediatric and adult patients with sickle cell disease
      M de Montalembert, D Bachir, A Hulin, L Gimeno, A Mogenet, JL Bresson, I Macquin-Mavier, F Roudot-Thoraval, A Astier, F Galacteros
      Haematologica Jan 2006, 91 (12) 1685-1688;

  11. Girelli, G

    1. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia
      W Barcellini, S Capalbo, RM Agostinelli, FR Mauro, A Ambrosetti, R Calori, A Cortelezzi, L Laurenti, EM Pogliani, P Pedotti, V Liso, G Girelli, F Mandelli, A Zanella, GIMEMA Chronic Lymphocytic Leukemia Group
      Haematologica Jan 2006, 91 (12) 1689-1692;

  12. Goldin, LR

    1. Respiratory tract infections in the pathway to multiple myeloma: a population-based study in Scandinavia
      O Landgren, JS Rapkin, L Mellemkjaer, G Gridley, LR Goldin, EA Engels
      Haematologica Jan 2006, 91 (12) 1697-1700;

  13. Gozzetti, A

    1. The effect of zoledronic acid on serum osteoprotegerin in early stage multiple myeloma
      G Martini, A Gozzetti, L Gennari, A Avanzati, R Nuti, F Lauria
      Haematologica Jan 2006, 91 (12) 1720-1721;

  14. Greiner, J

    1. Cancer vaccines for patients with acute myeloid leukemia--definition of leukemia-associated antigens and current clinical protocols targeting these antigens
      J Greiner, H Dohner, M Schmitt
      Haematologica Jan 2006, 91 (12) 1653-1661;

  15. Gridley, G

    1. Respiratory tract infections in the pathway to multiple myeloma: a population-based study in Scandinavia
      O Landgren, JS Rapkin, L Mellemkjaer, G Gridley, LR Goldin, EA Engels
      Haematologica Jan 2006, 91 (12) 1697-1700;

H

  1. Haas, R

    1. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes
      U Germing, C Strupp, A Kuendgen, S Isa, S Knipp, B Hildebrandt, A Giagounidis, C Aul, N Gattermann, R Haas
      Haematologica Jan 2006, 91 (12) 1596-1604;

  2. Heinecke, A

    1. Long-term safety and efficacy data on childhood venous thrombosis treated with a low molecular weight heparin: an open-label pilot study of once-daily versus twice-daily enoxaparin administration
      R Schobess, C During, C Bidlingmaier, A Heinecke, N Merkel, U Nowak-Gottl
      Haematologica Jan 2006, 91 (12) 1701-1704;

  3. Hildebrandt, B

    1. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes
      U Germing, C Strupp, A Kuendgen, S Isa, S Knipp, B Hildebrandt, A Giagounidis, C Aul, N Gattermann, R Haas
      Haematologica Jan 2006, 91 (12) 1596-1604;

  4. Hoogerbrugge, P

    1. B-cell recovery after stem cell transplantation of Artemis-deficient SCID requires elimination of autologous bone marrow precursor-B-cells
      M van der Burg, CM Weemaes, F Preijers, P Brons, BH Barendregt, MJ van Tol, P Hoogerbrugge, JJ van Dongen
      Haematologica Jan 2006, 91 (12) 1705-1709;

  5. Hulin, A

    1. Pharmacokinetics of hydroxyurea 1,000 mg coated breakable tablets and 500 mg capsules in pediatric and adult patients with sickle cell disease
      M de Montalembert, D Bachir, A Hulin, L Gimeno, A Mogenet, JL Bresson, I Macquin-Mavier, F Roudot-Thoraval, A Astier, F Galacteros
      Haematologica Jan 2006, 91 (12) 1685-1688;

  6. Hunt, BJ

    1. Managing antiphospholipid antibodies and antiphospholipid syndrome in children
      AV Kamat, DP D'Cruz, BJ Hunt
      Haematologica Jan 2006, 91 (12) 1674-1680;

I

  1. Isa, S

    1. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes
      U Germing, C Strupp, A Kuendgen, S Isa, S Knipp, B Hildebrandt, A Giagounidis, C Aul, N Gattermann, R Haas
      Haematologica Jan 2006, 91 (12) 1596-1604;

J

  1. Jaen, J

    1. The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma
      T Alvaro, M Lejeune, FI Camacho, MT Salvado, L Sanchez, JF Garcia, C Lopez, J Jaen, R Bosch, LE Pons, C Bellas, MA Piris
      Haematologica Jan 2006, 91 (12) 1605-1612;

  2. Janssen, HL

    1. Myeloproliferative disease in the pathogenesis and survival of Budd-Chiari syndrome
      JH Smalberg, SD Murad, E Braakman, PJ Valk, HL Janssen, FW Leebeek
      Haematologica Jan 2006, 91 (12) 1712-1713;

K

  1. Kamat, AV

    1. Managing antiphospholipid antibodies and antiphospholipid syndrome in children
      AV Kamat, DP D'Cruz, BJ Hunt
      Haematologica Jan 2006, 91 (12) 1674-1680;

  2. Karakantza, M

    1. Expression and inducibility of cytoprotective heat shock proteins in the bone marrow of patients with myelodysplastic syndrome: correlation with disease progression
      S Michalopoulou, I Micheva, M Karakantza, A Kouraklis-Symeonidis, A Mouzaki, NC Zoumbos
      Haematologica Jan 2006, 91 (12) 1714-1716;

  3. Knipp, S

    1. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes
      U Germing, C Strupp, A Kuendgen, S Isa, S Knipp, B Hildebrandt, A Giagounidis, C Aul, N Gattermann, R Haas
      Haematologica Jan 2006, 91 (12) 1596-1604;

  4. Kouraklis-Symeonidis, A

    1. Expression and inducibility of cytoprotective heat shock proteins in the bone marrow of patients with myelodysplastic syndrome: correlation with disease progression
      S Michalopoulou, I Micheva, M Karakantza, A Kouraklis-Symeonidis, A Mouzaki, NC Zoumbos
      Haematologica Jan 2006, 91 (12) 1714-1716;

  5. Kuendgen, A

    1. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes
      U Germing, C Strupp, A Kuendgen, S Isa, S Knipp, B Hildebrandt, A Giagounidis, C Aul, N Gattermann, R Haas
      Haematologica Jan 2006, 91 (12) 1596-1604;

L

  1. Landgren, O

    1. Respiratory tract infections in the pathway to multiple myeloma: a population-based study in Scandinavia
      O Landgren, JS Rapkin, L Mellemkjaer, G Gridley, LR Goldin, EA Engels
      Haematologica Jan 2006, 91 (12) 1697-1700;

  2. Lange, A

    1. CCR5 deletion mutation and its association with the risk of developing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
      K Bogunia-Kubik, D Duda, K Suchnicki, A Lange
      Haematologica Jan 2006, 91 (12) 1628-1634;

  3. Laurenti, L

    1. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia
      W Barcellini, S Capalbo, RM Agostinelli, FR Mauro, A Ambrosetti, R Calori, A Cortelezzi, L Laurenti, EM Pogliani, P Pedotti, V Liso, G Girelli, F Mandelli, A Zanella, GIMEMA Chronic Lymphocytic Leukemia Group
      Haematologica Jan 2006, 91 (12) 1689-1692;

  4. Lauria, F

    1. Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation
      M Brugiatelli, G Bandini, G Barosi, F Lauria, V Liso, M Marchetti, FR Mauro, G Meloni, PL Zinzani, S Tura, Italian Society of Hematology, Italian Society of Experimental Hematology, Italian Group for Bone Marrow Transplantation
      Haematologica Jan 2006, 91 (12) 1662-1673;
    2. The effect of zoledronic acid on serum osteoprotegerin in early stage multiple myeloma
      G Martini, A Gozzetti, L Gennari, A Avanzati, R Nuti, F Lauria
      Haematologica Jan 2006, 91 (12) 1720-1721;

  5. Leebeek, FW

    1. Myeloproliferative disease in the pathogenesis and survival of Budd-Chiari syndrome
      JH Smalberg, SD Murad, E Braakman, PJ Valk, HL Janssen, FW Leebeek
      Haematologica Jan 2006, 91 (12) 1712-1713;

  6. Lejeune, M

    1. The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma
      T Alvaro, M Lejeune, FI Camacho, MT Salvado, L Sanchez, JF Garcia, C Lopez, J Jaen, R Bosch, LE Pons, C Bellas, MA Piris
      Haematologica Jan 2006, 91 (12) 1605-1612;

  7. Liso, V

    1. Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation
      M Brugiatelli, G Bandini, G Barosi, F Lauria, V Liso, M Marchetti, FR Mauro, G Meloni, PL Zinzani, S Tura, Italian Society of Hematology, Italian Society of Experimental Hematology, Italian Group for Bone Marrow Transplantation
      Haematologica Jan 2006, 91 (12) 1662-1673;
    2. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia
      W Barcellini, S Capalbo, RM Agostinelli, FR Mauro, A Ambrosetti, R Calori, A Cortelezzi, L Laurenti, EM Pogliani, P Pedotti, V Liso, G Girelli, F Mandelli, A Zanella, GIMEMA Chronic Lymphocytic Leukemia Group
      Haematologica Jan 2006, 91 (12) 1689-1692;

  8. Lopez, C

    1. The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma
      T Alvaro, M Lejeune, FI Camacho, MT Salvado, L Sanchez, JF Garcia, C Lopez, J Jaen, R Bosch, LE Pons, C Bellas, MA Piris
      Haematologica Jan 2006, 91 (12) 1605-1612;

M

  1. Macquin-Mavier, I

    1. Pharmacokinetics of hydroxyurea 1,000 mg coated breakable tablets and 500 mg capsules in pediatric and adult patients with sickle cell disease
      M de Montalembert, D Bachir, A Hulin, L Gimeno, A Mogenet, JL Bresson, I Macquin-Mavier, F Roudot-Thoraval, A Astier, F Galacteros
      Haematologica Jan 2006, 91 (12) 1685-1688;

  2. Magaud, JP

    1. The expression of TCR-gamma delta/CD3 complex in neoplastic gamma delta T-cell
      L Baseggio, F Berger, G Monneret, JP Magaud, G Salles, P Felman
      Haematologica Jan 2006, 91 (12) 1717-1719;

  3. Maggio, A

    1. Analysis of delta-globin gene alleles in the Sicilian population: identification of five new mutations
      A Giambona, C Passarello, G Ruggeri, D Renda, P Teresi, M Anza, A Maggio
      Haematologica Jan 2006, 91 (12) 1681-1684;

  4. Magni, M

    1. Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis
      V Perfetti, S Siena, G Palladini, M Bregni, M Di Nicola, L Obici, M Magni, L Brunetti, AM Gianni, G Merlini
      Haematologica Jan 2006, 91 (12) 1635-1643;

  5. Mahe, I

    1. Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study
      I Mahe, N Bertrand, L Drouet, C Bal Dit Sollier, G Simoneau, E Mazoyer, C Caulin, JF Bergmann
      Haematologica Jan 2006, 91 (12) 1621-1627;

  6. Malcovati, L

    1. Predicting survival and leukemic evolution in patients with myelodysplastic syndrome
      L Malcovati, MG Della Porta, M Cazzola
      Haematologica Jan 2006, 91 (12) 1588-1590;

  7. Mandelli, F

    1. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia
      W Barcellini, S Capalbo, RM Agostinelli, FR Mauro, A Ambrosetti, R Calori, A Cortelezzi, L Laurenti, EM Pogliani, P Pedotti, V Liso, G Girelli, F Mandelli, A Zanella, GIMEMA Chronic Lymphocytic Leukemia Group
      Haematologica Jan 2006, 91 (12) 1689-1692;

  8. Marchetti, M

    1. Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation
      M Brugiatelli, G Bandini, G Barosi, F Lauria, V Liso, M Marchetti, FR Mauro, G Meloni, PL Zinzani, S Tura, Italian Society of Hematology, Italian Society of Experimental Hematology, Italian Group for Bone Marrow Transplantation
      Haematologica Jan 2006, 91 (12) 1662-1673;

  9. Martini, G

    1. The effect of zoledronic acid on serum osteoprotegerin in early stage multiple myeloma
      G Martini, A Gozzetti, L Gennari, A Avanzati, R Nuti, F Lauria
      Haematologica Jan 2006, 91 (12) 1720-1721;

  10. Marynen, P

    1. Splenic marginal zone lymphoma-like features in API2-MALT1 transgenic mice that are exposed to antigenic stimulation
      X Sagaert, T Theys, C De Wolf-Peeters, P Marynen, M Baens
      Haematologica Jan 2006, 91 (12) 1693-1696;

  11. Mauro, FR

    1. Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation
      M Brugiatelli, G Bandini, G Barosi, F Lauria, V Liso, M Marchetti, FR Mauro, G Meloni, PL Zinzani, S Tura, Italian Society of Hematology, Italian Society of Experimental Hematology, Italian Group for Bone Marrow Transplantation
      Haematologica Jan 2006, 91 (12) 1662-1673;
    2. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia
      W Barcellini, S Capalbo, RM Agostinelli, FR Mauro, A Ambrosetti, R Calori, A Cortelezzi, L Laurenti, EM Pogliani, P Pedotti, V Liso, G Girelli, F Mandelli, A Zanella, GIMEMA Chronic Lymphocytic Leukemia Group
      Haematologica Jan 2006, 91 (12) 1689-1692;

  12. Mazoyer, E

    1. Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study
      I Mahe, N Bertrand, L Drouet, C Bal Dit Sollier, G Simoneau, E Mazoyer, C Caulin, JF Bergmann
      Haematologica Jan 2006, 91 (12) 1621-1627;

  13. Mazzola, G

    1. Lipoprotein(a), fibrinogen and vascular mortality in an elderly northern Italian population
      A D'Angelo, G Ruotolo, P Garancini, F Sampietro, G Mazzola, G Calori
      Haematologica Jan 2006, 91 (12) 1613-1620;

  14. Mellemkjaer, L

    1. Respiratory tract infections in the pathway to multiple myeloma: a population-based study in Scandinavia
      O Landgren, JS Rapkin, L Mellemkjaer, G Gridley, LR Goldin, EA Engels
      Haematologica Jan 2006, 91 (12) 1697-1700;

  15. Meloni, G

    1. Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation
      M Brugiatelli, G Bandini, G Barosi, F Lauria, V Liso, M Marchetti, FR Mauro, G Meloni, PL Zinzani, S Tura, Italian Society of Hematology, Italian Society of Experimental Hematology, Italian Group for Bone Marrow Transplantation
      Haematologica Jan 2006, 91 (12) 1662-1673;

  16. Merkel, N

    1. Long-term safety and efficacy data on childhood venous thrombosis treated with a low molecular weight heparin: an open-label pilot study of once-daily versus twice-daily enoxaparin administration
      R Schobess, C During, C Bidlingmaier, A Heinecke, N Merkel, U Nowak-Gottl
      Haematologica Jan 2006, 91 (12) 1701-1704;

  17. Merlini, G

    1. Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis
      V Perfetti, S Siena, G Palladini, M Bregni, M Di Nicola, L Obici, M Magni, L Brunetti, AM Gianni, G Merlini
      Haematologica Jan 2006, 91 (12) 1635-1643;

  18. Michalopoulou, S

    1. Expression and inducibility of cytoprotective heat shock proteins in the bone marrow of patients with myelodysplastic syndrome: correlation with disease progression
      S Michalopoulou, I Micheva, M Karakantza, A Kouraklis-Symeonidis, A Mouzaki, NC Zoumbos
      Haematologica Jan 2006, 91 (12) 1714-1716;

  19. Micheva, I

    1. Expression and inducibility of cytoprotective heat shock proteins in the bone marrow of patients with myelodysplastic syndrome: correlation with disease progression
      S Michalopoulou, I Micheva, M Karakantza, A Kouraklis-Symeonidis, A Mouzaki, NC Zoumbos
      Haematologica Jan 2006, 91 (12) 1714-1716;

  20. Mogenet, A

    1. Pharmacokinetics of hydroxyurea 1,000 mg coated breakable tablets and 500 mg capsules in pediatric and adult patients with sickle cell disease
      M de Montalembert, D Bachir, A Hulin, L Gimeno, A Mogenet, JL Bresson, I Macquin-Mavier, F Roudot-Thoraval, A Astier, F Galacteros
      Haematologica Jan 2006, 91 (12) 1685-1688;

  21. Monneret, G

    1. The expression of TCR-gamma delta/CD3 complex in neoplastic gamma delta T-cell
      L Baseggio, F Berger, G Monneret, JP Magaud, G Salles, P Felman
      Haematologica Jan 2006, 91 (12) 1717-1719;

  22. Moreau-Gachelin, F

    1. Lessons from models of murine erythroleukemia to acute myeloid leukemia (AML): proof-of-principle of co-operativity in AML
      F Moreau-Gachelin
      Haematologica Jan 2006, 91 (12) 1644-1652;

  23. Mouzaki, A

    1. Expression and inducibility of cytoprotective heat shock proteins in the bone marrow of patients with myelodysplastic syndrome: correlation with disease progression
      S Michalopoulou, I Micheva, M Karakantza, A Kouraklis-Symeonidis, A Mouzaki, NC Zoumbos
      Haematologica Jan 2006, 91 (12) 1714-1716;

  24. Murad, SD

    1. Myeloproliferative disease in the pathogenesis and survival of Budd-Chiari syndrome
      JH Smalberg, SD Murad, E Braakman, PJ Valk, HL Janssen, FW Leebeek
      Haematologica Jan 2006, 91 (12) 1712-1713;

N

  1. Nowak-Gottl, U

    1. Long-term safety and efficacy data on childhood venous thrombosis treated with a low molecular weight heparin: an open-label pilot study of once-daily versus twice-daily enoxaparin administration
      R Schobess, C During, C Bidlingmaier, A Heinecke, N Merkel, U Nowak-Gottl
      Haematologica Jan 2006, 91 (12) 1701-1704;

  2. Nuti, R

    1. The effect of zoledronic acid on serum osteoprotegerin in early stage multiple myeloma
      G Martini, A Gozzetti, L Gennari, A Avanzati, R Nuti, F Lauria
      Haematologica Jan 2006, 91 (12) 1720-1721;

O

  1. Obici, L

    1. Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis
      V Perfetti, S Siena, G Palladini, M Bregni, M Di Nicola, L Obici, M Magni, L Brunetti, AM Gianni, G Merlini
      Haematologica Jan 2006, 91 (12) 1635-1643;

P

  1. Palladini, G

    1. Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis
      V Perfetti, S Siena, G Palladini, M Bregni, M Di Nicola, L Obici, M Magni, L Brunetti, AM Gianni, G Merlini
      Haematologica Jan 2006, 91 (12) 1635-1643;

  2. Passarello, C

    1. Analysis of delta-globin gene alleles in the Sicilian population: identification of five new mutations
      A Giambona, C Passarello, G Ruggeri, D Renda, P Teresi, M Anza, A Maggio
      Haematologica Jan 2006, 91 (12) 1681-1684;

  3. Pedotti, P

    1. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia
      W Barcellini, S Capalbo, RM Agostinelli, FR Mauro, A Ambrosetti, R Calori, A Cortelezzi, L Laurenti, EM Pogliani, P Pedotti, V Liso, G Girelli, F Mandelli, A Zanella, GIMEMA Chronic Lymphocytic Leukemia Group
      Haematologica Jan 2006, 91 (12) 1689-1692;

  4. Perfetti, V

    1. Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis
      V Perfetti, S Siena, G Palladini, M Bregni, M Di Nicola, L Obici, M Magni, L Brunetti, AM Gianni, G Merlini
      Haematologica Jan 2006, 91 (12) 1635-1643;

  5. Piris, MA

    1. The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma
      T Alvaro, M Lejeune, FI Camacho, MT Salvado, L Sanchez, JF Garcia, C Lopez, J Jaen, R Bosch, LE Pons, C Bellas, MA Piris
      Haematologica Jan 2006, 91 (12) 1605-1612;

  6. Pogliani, EM

    1. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia
      W Barcellini, S Capalbo, RM Agostinelli, FR Mauro, A Ambrosetti, R Calori, A Cortelezzi, L Laurenti, EM Pogliani, P Pedotti, V Liso, G Girelli, F Mandelli, A Zanella, GIMEMA Chronic Lymphocytic Leukemia Group
      Haematologica Jan 2006, 91 (12) 1689-1692;

  7. Pons, LE

    1. The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma
      T Alvaro, M Lejeune, FI Camacho, MT Salvado, L Sanchez, JF Garcia, C Lopez, J Jaen, R Bosch, LE Pons, C Bellas, MA Piris
      Haematologica Jan 2006, 91 (12) 1605-1612;

  8. Preijers, F

    1. B-cell recovery after stem cell transplantation of Artemis-deficient SCID requires elimination of autologous bone marrow precursor-B-cells
      M van der Burg, CM Weemaes, F Preijers, P Brons, BH Barendregt, MJ van Tol, P Hoogerbrugge, JJ van Dongen
      Haematologica Jan 2006, 91 (12) 1705-1709;

R

  1. Rapkin, JS

    1. Respiratory tract infections in the pathway to multiple myeloma: a population-based study in Scandinavia
      O Landgren, JS Rapkin, L Mellemkjaer, G Gridley, LR Goldin, EA Engels
      Haematologica Jan 2006, 91 (12) 1697-1700;

  2. Renda, D

    1. Analysis of delta-globin gene alleles in the Sicilian population: identification of five new mutations
      A Giambona, C Passarello, G Ruggeri, D Renda, P Teresi, M Anza, A Maggio
      Haematologica Jan 2006, 91 (12) 1681-1684;

  3. Roudot-Thoraval, F

    1. Pharmacokinetics of hydroxyurea 1,000 mg coated breakable tablets and 500 mg capsules in pediatric and adult patients with sickle cell disease
      M de Montalembert, D Bachir, A Hulin, L Gimeno, A Mogenet, JL Bresson, I Macquin-Mavier, F Roudot-Thoraval, A Astier, F Galacteros
      Haematologica Jan 2006, 91 (12) 1685-1688;

  4. Ruggeri, G

    1. Analysis of delta-globin gene alleles in the Sicilian population: identification of five new mutations
      A Giambona, C Passarello, G Ruggeri, D Renda, P Teresi, M Anza, A Maggio
      Haematologica Jan 2006, 91 (12) 1681-1684;

  5. Ruotolo, G

    1. Lipoprotein(a), fibrinogen and vascular mortality in an elderly northern Italian population
      A D'Angelo, G Ruotolo, P Garancini, F Sampietro, G Mazzola, G Calori
      Haematologica Jan 2006, 91 (12) 1613-1620;

S

  1. Sagaert, X

    1. Splenic marginal zone lymphoma-like features in API2-MALT1 transgenic mice that are exposed to antigenic stimulation
      X Sagaert, T Theys, C De Wolf-Peeters, P Marynen, M Baens
      Haematologica Jan 2006, 91 (12) 1693-1696;

  2. Salles, G

    1. The expression of TCR-gamma delta/CD3 complex in neoplastic gamma delta T-cell
      L Baseggio, F Berger, G Monneret, JP Magaud, G Salles, P Felman
      Haematologica Jan 2006, 91 (12) 1717-1719;

  3. Salvado, MT

    1. The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma
      T Alvaro, M Lejeune, FI Camacho, MT Salvado, L Sanchez, JF Garcia, C Lopez, J Jaen, R Bosch, LE Pons, C Bellas, MA Piris
      Haematologica Jan 2006, 91 (12) 1605-1612;

  4. Sampietro, F

    1. Lipoprotein(a), fibrinogen and vascular mortality in an elderly northern Italian population
      A D'Angelo, G Ruotolo, P Garancini, F Sampietro, G Mazzola, G Calori
      Haematologica Jan 2006, 91 (12) 1613-1620;

  5. Sanchez, L

    1. The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma
      T Alvaro, M Lejeune, FI Camacho, MT Salvado, L Sanchez, JF Garcia, C Lopez, J Jaen, R Bosch, LE Pons, C Bellas, MA Piris
      Haematologica Jan 2006, 91 (12) 1605-1612;

  6. Sanchorawala, V

    1. Adapting to AL amyloidosis
      DC Seldin, V Sanchorawala
      Haematologica Jan 2006, 91 (12) 1591-1595;

  7. Saxena, R

    1. Coagulation factor V gene analysis in five Indian patients: identification of three novel small deletions
      R Asselta, C Dall'Osso, S Duga, M Spreafico, R Saxena, ML Tenchini
      Haematologica Jan 2006, 91 (12) 1724-1726;

  8. Schepers, H

    1. Constitutive activation of NF-kappa B is not sufficient to disturb normal steady-state hematopoiesis
      H Schepers, BJ Eggen, JJ Schuringa, E Vellenga
      Haematologica Jan 2006, 91 (12) 1710-1711;

  9. Schmitt, M

    1. Cancer vaccines for patients with acute myeloid leukemia--definition of leukemia-associated antigens and current clinical protocols targeting these antigens
      J Greiner, H Dohner, M Schmitt
      Haematologica Jan 2006, 91 (12) 1653-1661;

  10. Schobess, R

    1. Long-term safety and efficacy data on childhood venous thrombosis treated with a low molecular weight heparin: an open-label pilot study of once-daily versus twice-daily enoxaparin administration
      R Schobess, C During, C Bidlingmaier, A Heinecke, N Merkel, U Nowak-Gottl
      Haematologica Jan 2006, 91 (12) 1701-1704;

  11. Schuringa, JJ

    1. Constitutive activation of NF-kappa B is not sufficient to disturb normal steady-state hematopoiesis
      H Schepers, BJ Eggen, JJ Schuringa, E Vellenga
      Haematologica Jan 2006, 91 (12) 1710-1711;

  12. Seldin, DC

    1. Adapting to AL amyloidosis
      DC Seldin, V Sanchorawala
      Haematologica Jan 2006, 91 (12) 1591-1595;

  13. Siena, S

    1. Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis
      V Perfetti, S Siena, G Palladini, M Bregni, M Di Nicola, L Obici, M Magni, L Brunetti, AM Gianni, G Merlini
      Haematologica Jan 2006, 91 (12) 1635-1643;

  14. Simoneau, G

    1. Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study
      I Mahe, N Bertrand, L Drouet, C Bal Dit Sollier, G Simoneau, E Mazoyer, C Caulin, JF Bergmann
      Haematologica Jan 2006, 91 (12) 1621-1627;

  15. Smalberg, JH

    1. Myeloproliferative disease in the pathogenesis and survival of Budd-Chiari syndrome
      JH Smalberg, SD Murad, E Braakman, PJ Valk, HL Janssen, FW Leebeek
      Haematologica Jan 2006, 91 (12) 1712-1713;

  16. Sonneveld, P

    1. Phase II multicenter study of arsenic trioxide, ascorbic acid and dexamethasone in patients with relapsed or refractory multiple myeloma
      KL Wu, M Beksac, J van Droogenbroeck, S Amadori, S Zweegman, P Sonneveld
      Haematologica Jan 2006, 91 (12) 1722-1723;

  17. Spreafico, M

    1. Coagulation factor V gene analysis in five Indian patients: identification of three novel small deletions
      R Asselta, C Dall'Osso, S Duga, M Spreafico, R Saxena, ML Tenchini
      Haematologica Jan 2006, 91 (12) 1724-1726;

  18. Strupp, C

    1. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes
      U Germing, C Strupp, A Kuendgen, S Isa, S Knipp, B Hildebrandt, A Giagounidis, C Aul, N Gattermann, R Haas
      Haematologica Jan 2006, 91 (12) 1596-1604;

  19. Suchnicki, K

    1. CCR5 deletion mutation and its association with the risk of developing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
      K Bogunia-Kubik, D Duda, K Suchnicki, A Lange
      Haematologica Jan 2006, 91 (12) 1628-1634;

T

  1. Tenchini, ML

    1. Coagulation factor V gene analysis in five Indian patients: identification of three novel small deletions
      R Asselta, C Dall'Osso, S Duga, M Spreafico, R Saxena, ML Tenchini
      Haematologica Jan 2006, 91 (12) 1724-1726;

  2. Teresi, P

    1. Analysis of delta-globin gene alleles in the Sicilian population: identification of five new mutations
      A Giambona, C Passarello, G Ruggeri, D Renda, P Teresi, M Anza, A Maggio
      Haematologica Jan 2006, 91 (12) 1681-1684;

  3. Theys, T

    1. Splenic marginal zone lymphoma-like features in API2-MALT1 transgenic mice that are exposed to antigenic stimulation
      X Sagaert, T Theys, C De Wolf-Peeters, P Marynen, M Baens
      Haematologica Jan 2006, 91 (12) 1693-1696;

  4. Tura, S

    1. Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation
      M Brugiatelli, G Bandini, G Barosi, F Lauria, V Liso, M Marchetti, FR Mauro, G Meloni, PL Zinzani, S Tura, Italian Society of Hematology, Italian Society of Experimental Hematology, Italian Group for Bone Marrow Transplantation
      Haematologica Jan 2006, 91 (12) 1662-1673;

V

  1. Valk, PJ

    1. Myeloproliferative disease in the pathogenesis and survival of Budd-Chiari syndrome
      JH Smalberg, SD Murad, E Braakman, PJ Valk, HL Janssen, FW Leebeek
      Haematologica Jan 2006, 91 (12) 1712-1713;

  2. van der Burg, M

    1. B-cell recovery after stem cell transplantation of Artemis-deficient SCID requires elimination of autologous bone marrow precursor-B-cells
      M van der Burg, CM Weemaes, F Preijers, P Brons, BH Barendregt, MJ van Tol, P Hoogerbrugge, JJ van Dongen
      Haematologica Jan 2006, 91 (12) 1705-1709;

  3. van Dongen, JJ

    1. B-cell recovery after stem cell transplantation of Artemis-deficient SCID requires elimination of autologous bone marrow precursor-B-cells
      M van der Burg, CM Weemaes, F Preijers, P Brons, BH Barendregt, MJ van Tol, P Hoogerbrugge, JJ van Dongen
      Haematologica Jan 2006, 91 (12) 1705-1709;

  4. van Droogenbroeck, J

    1. Phase II multicenter study of arsenic trioxide, ascorbic acid and dexamethasone in patients with relapsed or refractory multiple myeloma
      KL Wu, M Beksac, J van Droogenbroeck, S Amadori, S Zweegman, P Sonneveld
      Haematologica Jan 2006, 91 (12) 1722-1723;

  5. van Tol, MJ

    1. B-cell recovery after stem cell transplantation of Artemis-deficient SCID requires elimination of autologous bone marrow precursor-B-cells
      M van der Burg, CM Weemaes, F Preijers, P Brons, BH Barendregt, MJ van Tol, P Hoogerbrugge, JJ van Dongen
      Haematologica Jan 2006, 91 (12) 1705-1709;

  6. Vellenga, E

    1. Constitutive activation of NF-kappa B is not sufficient to disturb normal steady-state hematopoiesis
      H Schepers, BJ Eggen, JJ Schuringa, E Vellenga
      Haematologica Jan 2006, 91 (12) 1710-1711;

W

  1. Weemaes, CM

    1. B-cell recovery after stem cell transplantation of Artemis-deficient SCID requires elimination of autologous bone marrow precursor-B-cells
      M van der Burg, CM Weemaes, F Preijers, P Brons, BH Barendregt, MJ van Tol, P Hoogerbrugge, JJ van Dongen
      Haematologica Jan 2006, 91 (12) 1705-1709;

  2. Wu, KL

    1. Phase II multicenter study of arsenic trioxide, ascorbic acid and dexamethasone in patients with relapsed or refractory multiple myeloma
      KL Wu, M Beksac, J van Droogenbroeck, S Amadori, S Zweegman, P Sonneveld
      Haematologica Jan 2006, 91 (12) 1722-1723;

Z

  1. Zanella, A

    1. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia
      W Barcellini, S Capalbo, RM Agostinelli, FR Mauro, A Ambrosetti, R Calori, A Cortelezzi, L Laurenti, EM Pogliani, P Pedotti, V Liso, G Girelli, F Mandelli, A Zanella, GIMEMA Chronic Lymphocytic Leukemia Group
      Haematologica Jan 2006, 91 (12) 1689-1692;

  2. Zinzani, PL

    1. Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation
      M Brugiatelli, G Bandini, G Barosi, F Lauria, V Liso, M Marchetti, FR Mauro, G Meloni, PL Zinzani, S Tura, Italian Society of Hematology, Italian Society of Experimental Hematology, Italian Group for Bone Marrow Transplantation
      Haematologica Jan 2006, 91 (12) 1662-1673;

  3. Zoumbos, NC

    1. Expression and inducibility of cytoprotective heat shock proteins in the bone marrow of patients with myelodysplastic syndrome: correlation with disease progression
      S Michalopoulou, I Micheva, M Karakantza, A Kouraklis-Symeonidis, A Mouzaki, NC Zoumbos
      Haematologica Jan 2006, 91 (12) 1714-1716;

  4. Zweegman, S

    1. Phase II multicenter study of arsenic trioxide, ascorbic acid and dexamethasone in patients with relapsed or refractory multiple myeloma
      KL Wu, M Beksac, J van Droogenbroeck, S Amadori, S Zweegman, P Sonneveld
      Haematologica Jan 2006, 91 (12) 1722-1723;
Back to top

In this issue

Jump to

What about you?
Tell us your interests and get all the new contents of Haematologica in advance
 

 

 
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale
Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma
Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring
Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial